Baicalin induces apoptosis in leukemia HL-60/ADR cells via possible down-regulation of the PI3K/AKT signaling pathway

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 4, 2012, Pages 1119-1124

  Zheng, Jing ^a   Hu, Jian Da ^a   Chen, Ying Yu ^a   Chen, Bu Yuan ^a   Huang, Yi ^b   Zheng, Zhi Hong ^a   Liu, Ting Bo ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

^b FUJIAN PROVINCIAL HOSPITAL   (China)

Author keywords

Akt signaling pathway; Apoptosis; Baicalin; Hl 60 adr cells

Indexed keywords

BAD PROTEIN, HUMAN; BAICALIN; CASPASE 3; ENZYME INHIBITOR; FLAVONOID; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MTOR PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAD; PROTEIN BCL 2; PROTEIN KINASE B; TARGET OF RAPAMYCIN KINASE;

APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL STRAIN HL 60; DOWN REGULATION; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION; GENETICS; HUMAN; METABOLISM; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

APOPTOSIS; BCL-ASSOCIATED DEATH PROTEIN; CASPASE 3; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; DRUGS, CHINESE HERBAL; ENZYME INHIBITORS; FLAVONOIDS; G0 PHASE; G1 PHASE; GENE EXPRESSION; HL-60 CELLS; HUMANS; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES;

EID: 84871896482     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.4.1119     Document Type: Article

References (26)

1. Chen BY, Hu JD, Chen XJ, et al (2008). Differentiation-inducing effects of baicalin on HL-60 leukemia cells. Chinese J Pathophysiol, 8, 66-8.
2. Cui YF, Shi L, Qin H, et al (2009). Research progress in mechanisms of the anticancer effects of green tea polyphenol (-) -epigallocatechin-3-gallate. World Chinese J Digestol, 3, 229-35.
3. Du G, Han G, Zhang S, et al (2010). Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF- 1alpha inhibition. Eur J Pharmacol, 630, 121-30.
4. Friedrichs N, Trautmann M, Endl E, et al (2011). Phosphatidylinositol-3'-kinase/AKT signaling is essential in synovial sarcoma. Int J Cancer, 129, 1564-75.
5. Harikumar KB, Kunnumakkara AB, Ahn KS, et al (2009). Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiation of apoptosis in leukemia cells. Blood, 113, 2003-13.
6. Hoffman B, Liebermann DA (2008). Apoptotic signal by c-MYC. Oncogene, 27, 6462-72.
7. Ivana Scovassi A, Diederich M (2004). Modulation of poly (ADP-ribosylation) in apoptotic cells. Biochem Pharmacol, 68, 1041-7.
8. Jucker M, Sudel K, Horn S, et al (2002). Expression of a mutated form of the p85alpha regulatory subunit of phosphatidylinositl 3-kinase in a Hodgkins lymphomaderived cell line (CO). Leukemia, 16, 894-901.
9. Kawauchi K, Ogasawara T, Yasuyama M, et al (2009). The PI3K/ Akt pathway as a target in the treatment of hematologic malignancies. Anticancer Agents Med Chem, 9, 550-9.
10. Levine DA, Bogomolniy F, Yee CJ, et al (2005). Frequent mutation of the PIK3CA gene in ovarian and breast cancer. Clin Cancer Res, 11, 2875-8.
11. Liu BC, Xiao ZJ (2008). Effect of meisoindigo on AKT signaling pathway and its role in apoptosis triggered by meisoindigo in Jurkat cells. J Clinic Hematol, 21, 255-9.
12. Marinov M, Ziogas A, Pardo OE, et al (2009). AKT/mTOR pathway activation and BCL-2 family proteins modulate the sensitivity of human small cell lung cancer cells to RAD001. Clin Cancer Res, 15, 1277-1287.
13. Miocinovic R, McCabe NP, Keck RW, et al (2005). In vivo and in vitro effect of baicalein on human prostate cancer cells. Int J Oncol, 26, 241-6.
14. Oda K, Stokoe D, Taketani Y, et al (2005). High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma. Cancer Res, 65, 10669-73.
15. Shieh DE, Cheng HY, Yen MH, et al (2006). Baicalin-induced apoptosis is mediated by Bcl-2-dependent, but not p53- dependent, pathway human leukemia cell lines. Am J Chin Med, 34, 245-61.
16. Sun CH, Chang YH, Pan CC (2011). Activation of the PI3K/ Akt/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder. Histopathology, 58, 1054-63.
17. Vandermoere F, El Yazidi-Belkoura I, Adriaenssens E, et al (2005). The Antiapoptotic effect of fibroblast growth factor-2 is mediated through nuclear factor-KB activation induced via interaction between Akt and IKB kinase-B in breast cancer cells. Oncogene, 24, 5482-91.
18. Wang JY, Wang ZP, Zhao JL, et al (2011). Curcumin induces Apoptosis via PTEN /PI3K/Akt pathway in human bladder carcinoma EJ cells. World J Onco, 27, 26-8.
19. Wang N, Tang LJ, Zhu GQ, et al (2008). Apoptosis induced by baicalin involving up-regula- tion of P53 and bax in MCF-7 cell. J Asian Nat Prod Res, 10, 1129-35.
20. Wierstra I, Alves J (2008). The c-myc promoter: still mystery and challenge. Adv Cancer Res, 99, 113-33.
21. Worf BB, Green DR (1999). Suicidal tendencies: apoptotic cell death by caspase family proteinase. J Biol Chem, 274, 20049-52.
22. Xu Q, Simpson SE, Scialla TJ, et al (2003). Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood, 102, 972-80.
23. Xu XM, Zhang Y, Li SQ, et al (2011). Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells by modulating PI3K/Akt pathway. J Exp Clin Canc Res, 29, 30-3.
24. Zhang X, Ge YL, Tian RH (2009). The knockdown of c-myc expression by RNAi inhibits cell proliferation in human colon cancer HT-29 cells in vitro and in vivo. Cell Mol Biol Lett, 14, 305-18.
25. Zheng HY, Hu JD, Zheng ZH et al (2007).Emodin induces leukemic HL-60 cells apoptosis probably by inhibiting Akt signal pathway. Acta Pharmaceutica Sinica, 42, 1142-6.
26. Zheng J, Hu JD, Huang Y, et al (2009).Effects of baicalin on proliferation and apoptosis of adriamycin-resistant human leukemia HL-60/ADR cells. Zhongguo Shi Yan Xue Ye Xue Za Zhi (Chinese), 17, 1198-202.